Creating Partnership for Life - Company Overview - YH Kim E-WHA Biomedics Co. Ltd. Tel.+82.2.2055.3820 Fax.+82.2.2055.3819 1
Company Overview Company name CEO Mr. Yong Hyun Kim E-Wha Biomedics Co. Ltd. Foundation date November, 1990 Main items Ambulatory Infusion Device and other 12 items Number of employees 65 Turnover US$ 8,660,000 / year (Based on in 2014y) Property status Total asset: US$ 7,300,000 Main Office(sales office) Factory 1-4 Myungryoon 1-ga, Jongno-gu, Seoul, Korea 1229 Jugyo-dong, Deogyang-gu, Goyang-si, Gyeonggi-do, Korea 2
Company History 1990, Foundation of E-Wha International Inc. by Yonghyun Kim. The Company started as a distributor for elastomeric disposables (Baxter IV system, pharmacy division products) HISTORY 1/2 1996, Evolved into an innovation-oriented infusion pump business 1998, Started Somanetics & Bard business as exclusive distributor 1999, Started co-development for Anapa pumps with KAIST (Korea Advanced Institute of Science and Technology) 2001, Anapa innovative technology approved by KFDA and Anapa registered in Korea Health insurance (HIRA) and its sale started 2003, Acquired ISO 9001, 13485, CE mark for Anapa 2004, Achieved US Patent for Anapa 3
Company History 2005, E-Wha Biomedics and E-Wha Fresenius Kabi separated from E-Wha International to organize two independent companies 2007, E-Wha Biomedics Ilsan factory established and started 4 production lines HISTORY 1/2 2008, E-Wha Biomedics achieved ISO 9001, 140001 Started manufacturing BrainSensor as OEM 2009, E-Wha Biomedics R& D center established 2011, Received CE certificate BIOLINE White - Central Venous Catheterization Set 2014, The contract was terminated with Fresenius-Kabi 2015, Selected high-growth companies from Small and Medium Business Administration 4
Organizational Structure President Sales & Marketing Production R&D Center Administration Sales Marketing Production New Products Financing Sales Supports Domestic & International RA & QM Production Technology Purchasing 5
Sales & Marketing Structure Team Number of Employee Details Sales 8-1 Sales Director - 3 sub-teams based on the teritory and hospital affiliation - Sales 3 team is focus on local hospitals Marketing 3 - Clinical Specialist - International Marketing - Domestic Marketing Sales Support 1 - Sales Supporting Jobs 6
Sales Manpower Seoul Gyeonggi-do Chungchungnam -do Jeonrabuk-do Gangwon-do Chungchungbuk -do Gyeongsanbukdo Direct Sales by E-Wha sales team (Blue box) : Seoul, Gyeonggi-do, Gangwon-do, Chungchungnam-do Sales by Local Distributor (red box) : Chunchungbuk-do, Jeonranam-do, Jeonrabuk-do, Gyeongsangnam-do, Gyeongsangbuk-do Jeonranam-do Gyeongsannam-do 7
Main Products Main Product Manufacturer Using department Sales (ea/month) ANAPA (infusion pump) INVOS & Brainsensor (Cerebral oximeter & sensor) Statlock (catheter securement system) E-Wha Anesthesiology, Oncology. About 17,000 ea Covidien (U.S.A) Anesthesiology About 24,000 ea Bard (U.S.A) All departments 18,000 ea Closed Suction Catheter with Circuit E-Wha Anesthesiology 2,600 ea E-temp (temperature probe) E-Wha Emergency Room, Anesthesiology 2,500 ea Anaport (chemoport needle) E-Wha Oncology. 65,000 ea 8
Main Products ANAPA (Continuous type) ANAPA PLUS (Bolus type) 9
Main Products INVOS system Brainsensor 10
Main Products Statlock Epidural StatLock Aterial StatLock IV StatLock CV Plus Multipurpose StatLock Foley Universial Plus StatLock Dialysis 11
Main Products E-temp (temperature probe) 12
Main Products Closed Suction Catheter with Circuit Anaport 13
Main Hospitals * Main Hospitals which E-Wha worked with; Main Hospital Location Total Beds The case of Anesthesia ASAN Medical Center Soeul 2,700 47,433 SAMSUNG Medical Center Soeul 2,000 56,425 INHA University Hospital Seoul 900 10,871 Seoul National University Bundang Hospital Seoul 1,400 31,612 SEVERANCE Hospital Seoul 2,500 59,160 14
Domestic Distribution Lean organizational structure allows for best possible decision-making processes Currently, the ANAPA system addresses both homecare and hospital settings. Homecare market is still in its infancy. More than 50 percent of the general acute and maximum care hospitals (over 500 beds) in South Korea are using ANAPA pumps exclusively or partially in addition to balloon type devices or electronic pumps. The hospitals highly appreciate ANAPA s excellent technical product features including ease of use, accuracy, flow rate control, ease of fill, safety and reliability. The infusion set is recognized as a superior system ensuring minimal implication on patients condition during infusion delivery. 15
Business Strength Lean organizational structure allows for best possible decision-making processes Over 25 years of experience in Oncology/Hematology and Anesthesia/Pain management Comprehensive understanding in Cardiology and Interventional Radiology Professional background in sales and marketing, administration, and technical support Our sales efforts are enhanced by the strong personnel relationships with most of administrative and healthcare professionals in numerous departments of Anesthesiology/Oncology. 16
Korea Device Regulation Lean organizational structure allows for best possible decision-making processes According to KFDA rules and regulations affecting the medical devices, the products must -Be approved by KFDA -Achieve KGMP license -Be registered on the HIRA(Health Insurance Review & Assessment) system. Korean Ministry of Health and Welfare tends to be supportive for local manufacturers to encourage the national healthcare industry. E-Wha has played a part in helping to facilitate better methods and procedures to market new innovative products in South Korea, having a lot of experiences and successful cases in obtaining KFDA approval and registering in HIRA system without fail. 17
Thank you! Office : 1-4 Myeongnyun 1ga, Jongno-gu, Seoul 110-521 Korea Tel.+82.2.2055.3820 Fax.+82.2.2055.3819 Factory : 1229 Jugyo-dong, Goyang-si, Gyeonggi-do 412-813 Korea President : Yonghyun Kim YH Kim E-WHA Biomedics Co. Ltd. Tel.+82.2.2055.3820 Fax.+82.2.2055.3819 18